95 related articles for article (PubMed ID: 6508434)
1. Development of tolerance to guanethidine in three hypertensive rat models.
Rankin GO; Watkins BE; Sawutz DG
Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):263-74. PubMed ID: 6508434
[TBL] [Abstract][Full Text] [Related]
2. Effects of captopril on the development of tolerance to guanethidine.
Rankin GO; Haas GJ
Fed Proc; 1984 Apr; 43(5):1342-5. PubMed ID: 6323227
[TBL] [Abstract][Full Text] [Related]
3. Chlorpromazine interactions with guanethidine and alpha-methyldopa: effects on arterial pressure control and heart rate in renovascular hypertensive rats.
Rankin GO; Watkins BE; Sawutz DG
Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):130-40. PubMed ID: 7165417
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
Ishii R; Tagawa T; Ishida T; Naruse T
Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
[TBL] [Abstract][Full Text] [Related]
5. [Acute tolerance to the hypotensive effect of pindolol in spontaneously hypertensive rats (SHR)].
Matsunaga K; Ueda M
Nihon Yakurigaku Zasshi; 1983 Oct; 82(4):259-66. PubMed ID: 6141128
[TBL] [Abstract][Full Text] [Related]
6. The response to arachidonic acid before and after non-steroidal anti-inflammatory drugs in normotensive and hypertensive rats.
Hill SR; Smith AJ
J Hypertens; 1994 Aug; 12(8):891-9. PubMed ID: 7814848
[TBL] [Abstract][Full Text] [Related]
7. [Antihypertensive effects of labetalol in three types of hypertensive models of rats (author's transl)].
Nakagawa Y; Takeda K; Sakurai H; Mitomi A; Imai S
Nihon Yakurigaku Zasshi; 1981 Apr; 77(4):435-45. PubMed ID: 7286847
[TBL] [Abstract][Full Text] [Related]
8. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
[TBL] [Abstract][Full Text] [Related]
9. [Effect of ketanserin on arterial baroreflex-blood pressure control in conscious hypertensive rats].
Kong XB; Cheng Y; Su DF
Zhongguo Yao Li Xue Bao; 1992 Nov; 13(6):517-20. PubMed ID: 1302438
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
Ueda M; Matsumura S; Masui M; Matsuura E; Kawakami M; Fujitomo H; Umeda T; Kagawa H; Hirohata S; Shima K
Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
[TBL] [Abstract][Full Text] [Related]
11. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
12. Renal interleukin-6 production in normotensive and hypertensive rats.
Nakamura A; Kohsaka T; Johns EJ
J Hypertens; 1994 Mar; 12(3):239-43. PubMed ID: 8021476
[TBL] [Abstract][Full Text] [Related]
13. Haemodynamic response to magnesium administration in mineralocorticoid-salt and two-kidney, one clip renovascular hypertension.
DiPette DJ; Simpson K; Rogers A; Holland OB
J Hypertens; 1988 May; 6(5):413-7. PubMed ID: 3385207
[TBL] [Abstract][Full Text] [Related]
14. Calcium sensitivity and cardiac performance in genetic and renal models of hypertension.
Raine AE; Roberts AF; Manley BS; Jones JV; Ledingham JG
J Hypertens Suppl; 1983 Dec; 1(2):85-7. PubMed ID: 6599502
[TBL] [Abstract][Full Text] [Related]
15. Antihypertensive properties of the novel calcium antagonist (1S,2S)-2-[2-[[3-(2-benzimidazolyl)propyl]methylamino] ethyl]-6- fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate dihydrochloride in rat models of hypertension. Comparison with verapamil.
Hefti F; Clozel JP; Osterrieder W
Arzneimittelforschung; 1990 Apr; 40(4):417-21. PubMed ID: 2357242
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
Okamiya Y; Kishimoto T; Sunakawa K; Aoki K; Tanabe H; Takeshita T; Naruchi T
Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
[TBL] [Abstract][Full Text] [Related]
17. Y-27152, a long-acting K+ channel opener with less tachycardia: antihypertensive effects in hypertensive rats and dogs in conscious state.
Nakajima T; Shinohara T; Yaoka O; Fukunari A; Shinagawa K; Aoki K; Katoh A; Yamanaka T; Setoguchi M; Tahara T
J Pharmacol Exp Ther; 1992 May; 261(2):730-6. PubMed ID: 1578381
[TBL] [Abstract][Full Text] [Related]
18. Low-intensity voluntary running lowers blood pressure with simultaneous improvement in endothelium-dependent vasodilatation and insulin sensitivity in aged spontaneously hypertensive rats.
Sun MW; Qian FL; Wang J; Tao T; Guo J; Wang L; Lu AY; Chen H
Hypertens Res; 2008 Mar; 31(3):543-52. PubMed ID: 18497475
[TBL] [Abstract][Full Text] [Related]
19. Role of bradykinin in chronic antihypertensive actions of ramipril in different hypertension models.
Bao G; Gohlke P; Unger T
J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S96-9. PubMed ID: 1282637
[TBL] [Abstract][Full Text] [Related]
20. Arterial effects of angiotensin converting enzyme inhibition in renovascular and spontaneously hypertensive rats.
Levy BI; Michel JB; Salzmann JL; Azizi M; Poitevin P; Camilleri JP; Safar ME
J Hypertens Suppl; 1988 Dec; 6(3):S23-5. PubMed ID: 3225686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
